ADVERTISEMENT

Dow climbs 230 points as investors gear up for earnings season

US stock indexes rose on Monday as investors prepared for upcoming earnings reports, which will provide details around the impact of coronavirus on companies.

ADVERTISEMENT

US equities gained on Monday as investors prepared for earnings reports that will show the degree of damage imposed by the coronavirus.

PepsiCo jumped in early trading after revealing better-than-expected revenue in the second quarter. The report marked the unofficial start of an earnings season set to be more chaotic than usual.

Several companies pulled forward guidance in their previous reports, citing uncertainties sourced from the coronavirus pandemic. Investors now wait to see which corporate giants outperformed and which faltered throughout widespread lockdowns.

ADVERTISEMENT

Here's where US indexes stood shortly after the 9:30 a.m. ET market open on Monday:

Major banks kick off earnings season on Tuesday, with JPMorgan , Citigroup , and Wells Fargo all slated to release quarterly metrics. The firms are expected to show a sharp decline in profits due to bolstered loan-loss reserves and weakened net interest income.

In deal news, Maxim Integrated Products leaped after rival firm Analog Devices said it would purchase the firm in a $21 billion all-stock deal. The takeover is among the year's largest.

ADVERTISEMENT

Pfizer and BioNTech gained after two of the firms' coronavirus vaccine candidates received "fast track" status from the Food and Drug Administration. Both companies have said they plan to produce as many as 100 million doses by the end of 2020 if their vaccine gains regulatory approval. A trial with up to 30,000 participants can begin as soon as later this month, they added.

Oil declined amid fears of OPEC+ retracing production cuts in its Wednesday meeting. West Texas Intermediate crude slid as much as 2.2%, to $39.66 per barrel. Brent crude , the international benchmark, fell 2%, to $42.39 per barrel, at intraday lows.

The stock market's gains follow a positive close to the previous week. Equities climbed roughly 1% on Friday as investors cheered a different coronavirus vaccine candidate. Gilead Sciences announced trial data for its remdesivir compound found a 62% reduction to mortality risk among severe COVID patients. Banks including Goldman Sachs ,Wells Fargo, andCitigroupalso jumped through the session.

Now read more markets coverage from Markets Insider and Business Insider:

ADVERTISEMENT

See Also:

ADVERTISEMENT

FOLLOW BUSINESS INSIDER AFRICA

Unblock notifications in browser settings.
ADVERTISEMENT

Recommended articles

Kenyan government rejects calls to ban TikTok, recommends tighter control over

Kenyan government rejects calls to ban TikTok, recommends tighter control over

Congo accuses Apple of conflict minerals in its supply chain

Congo accuses Apple of conflict minerals in its supply chain

Top 10 African countries with the highest fuel prices in April 2024

Top 10 African countries with the highest fuel prices in April 2024

The gold trade in Uganda makes a huge comeback

The gold trade in Uganda makes a huge comeback

Best live dealer casino: Top USA live casinos online

Best live dealer casino: Top USA live casinos online

Best real money online casinos USA: Top 10 casino sites in 2024

Best real money online casinos USA: Top 10 casino sites in 2024

OPEC excited about partnership with Namibia

OPEC excited about partnership with Namibia

The US loses to Russia and China in popularity across Africa

The US loses to Russia and China in popularity across Africa

Top 10 most valuable South African brands in 2024

Top 10 most valuable South African brands in 2024

ADVERTISEMENT